Treatment strategies in coronary microvascular dysfunction: A systematic review of interventional studies
- 15 April 2019
- journal article
- review article
- Published by Wiley in Microcirculation
- Vol. 26 (3) , e12430
Abstract
CMD has been associated with a wide spectrum of diseases and conditions, and it has proven to be a strong prognostic marker of morbidity and mortality. Despite increased attention, guideline‐based treatment recommendations are lacking. We performed a systematic review of pharmacological and nonpharmacological interventions to improve coronary perfusion, assessed by IC Doppler, TTDE, PET, CMRI, transthoracic contrast perfusion echocardiography, and dilution techniques. No restrictions were made regarding the study design (randomized, placebo‐controlled/randomized with active comparators/nonrandomized with or without a control group), the cardiac condition studied, or the coronary microvascular function at baseline. An electronic database search yielded 4485 records of which 80 studies met our inclusion criteria. Included studies were sorted according to intervention and study design. Studies were small and heterogeneous in methodology, and only few were placebo‐controlled. Although some treatments looked promising, we found that no specific treatment was sufficiently well documented to be recommended in any patient groups. There is a need for larger well‐designed clinical trials, and we suggest that future studies stratify study populations according to pathogenic mechanisms, thereby investigating whether an individualized treatment approach would be more successful.Keywords
Funding Information
- Det Frie Forskningsråd
This publication has 105 references indexed in Scilit:
- Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery diseaseCardiovascular Diabetology, 2013
- Atorvastatin Treatment Improves Myocardial and Peripheral Blood Flow in Familial Hypercholesterolemia Subjects without Evidence of Coronary AtherosclerosisEchocardiography, 2012
- In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)American Heart Journal, 2011
- Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected IschemiaJACC, 2010
- Improvement in coronary endothelial function is independently associated with a slowed progression of coronary artery calcification in type 2 diabetes mellitusEuropean Heart Journal, 2009
- Diffuse, marked, reversible impairment in coronary microcirculation in stress cardiomyopathy: A Doppler transthoracic echo studyAnnals of Medicine, 2009
- Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathyHeart, 2007
- Different effects of atenolol and nebivolol on coronary flow reserveHeart, 2006
- Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathyHeart, 2006
- Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetesHeart, 2006